Literature DB >> 8814483

Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia.

S C Marriage, H Underhill, S Nadel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8814483     DOI： 10.1007/bf01708109

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  L J Bernstein; M R Bye; A Rubinstein
Journal:  Am J Dis Child       Date:  1989-07

2.  Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients.

Authors:  R Escamilla; M C Prevost; C Hermant; A Caratero; C Cariven; M Krempf
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

3.  Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii-related respiratory failure.

Authors:  G E McLaughlin; S S Virdee; C L Schleien; B H Holzman; G B Scott
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

4.  Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia.

Authors:  A G Hoffman; M G Lawrence; F P Ognibene; A F Suffredini; G Y Lipschik; J A Kovacs; H Masur; J H Shelhamer
Journal:  Chest       Date:  1992-12       Impact factor: 9.410

5.  Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia.

Authors:  A J Slater; S H Nichani; D Macrae; K A Wilkinson; V Novelli; R C Tasker
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440
  5 in total
  3 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 2.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

3.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.